[STEROID METABOLISM AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF CORTISONE AND HYDROCORTISONE IN MASTOPATHY AND BREAST CANCER].
D015068:17-Ketosteroids; D061605:Administration, Intravenous; D001941:Breast Diseases; D001943:Breast Neoplasms; D003348:Cortisone; D045166:Estradiol Congeners; D004967:Estrogens; D006801:Humans; D006854:Hydrocortisone; D007275:Injections, Intravenous; D008660:Metabolism; D014556:Urine
D015068:17-Ketosteroids; D045166:Estradiol Congeners; D004967:Estrogens; D003348:Cortisone; D006854:Hydrocortisone
17-KETOSTEROIDS; BREAST DISEASES; BREAST NEOPLASMS; CORTISONE; ESTROGENS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; METABOLISM; URINE
DER STEROIDSTOFFWECHSEL NACH ORALER UND INTRAVENOESER APPLIKATION VON CORTISON UND HYDROCORTISON BEI MASTOPATHIE UND BRUSTKREBS.